C反应蛋白与急性冠脉综合征及临床应用
摘要
炎症机制在急性冠脉综合征中起重要作用,炎症生物标记物———C反应蛋白水平与急性冠脉综合征的发生和预后有密切关系,且被诸多的临床试验证实。因此,C反应蛋白在冠心病的预防中具有重要价值。
出处
《天津药学》
2006年第1期43-45,共3页
Tianjin Pharmacy
参考文献15
-
1Wei-Hsian Yin,Jaw-Wen Chen.Independent prognostic value of elevated high sensitivity C-reactive protein in chronic heart failure.Am Heart J,2004,147(5):931
-
2Libby P.Current concepts of the pathogenesis of the acute coronary syndromes.Circulation,2001,104:365
-
3Chandra H R,Choudhary N,O' Neill C,et al.Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome.AmJ Cardiol,2001,88:214
-
4Ridker P M,Rifai N,Rose L,et al.Comparison of C-recative protein and low-density lipoprotein cholesterol levels in the prediction of first caidiovascular events.N Engl J Med,2002,347:1557
-
5Cannon C J,Braunwald E,McCabe C H.For the pravestatin or atorvastatin evaluation and infection therapy:Thrombolysis in myocardial infarction 22investigators.Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes.N Engl J Med,2004,350:1495
-
6Mehta S R,McQueen J M,Smieja M,et al.Baseline high-sensitivity C -reactive protein offers prognostic value in addition to contemporary risk stratification in non-ST-segment elevation acute coronary syndrome:results from the CURE inflammatory marker substudy.Circulation,2004,110:498
-
7Yusuf S,Zhao F,Mehta S R.The clopidogrel in unstable angina to prevent recurrent events trial investigators.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J,2001,345:494
-
8Meade T,Zuhrie R,Cook C,et al.Bezafibrate in men with lower extremity arterial disease randomised controlled trial.BMJ,2002,325:1139
-
9H.Gomma,Hirschfield.Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting.Am Heart J,2004,147(6):1071
-
10Pearson T A,Mensah G A,Alexander R W,et al.Markers of inflammation and cardiovascular disease.Application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the american heart association.Circulation,2003,107:499
-
1王廷涛,张效明,张俊,刘群,武文君,陈燕,熊守庆.急性冠状动脉综合征的炎症机制及氟伐他汀的抗炎作用[J].蚌埠医学院学报,2009,34(6):501-503. 被引量：1
-
2陈文彬.注意哮喘发病的炎症机制及治疗的新动向[J].中华内科杂志,1992,31(12):739-740.
-
3刘晔,彭永德.胰岛素抵抗的炎症机制及防治策略[J].世界临床药物,2012,33(3):190-192. 被引量：5
-
4赵芳芳,王季猛,程灿.糖尿病肾病发病机制研究进展[J].现代生物医学进展,2010,10(24):4796-4798. 被引量：22
-
5胡昌军,张爱华.慢性砷中毒的生物标记物及临床意义[J].中国地方病学杂志,1998,17(4):265-267. 被引量：3
-
6李芳,余素琴,杜艳华.急性冠脉综合征的炎症机制[J].内科急危重症杂志,2007,13(3):159-160. 被引量：3
-
7王金会,包卫方,李振光,于占彩.阵发性心房颤动的生物标记物[J].国际医药卫生导报,2016,22(7):1033-1036.
-
8贾伟平.2型糖尿病及其慢性并发症早期预警生物标记物的研究[J].中华医学信息导报,2015,0(24):11-11. 被引量：1
-
9汪年松,王锋.糖尿病肾病的炎症机制和防治[J].中国中西医结合肾病杂志,2010,11(2):98-101. 被引量：16
-
10吴炳祥.浅谈射血分数正常的心力衰竭患者相关生物标记物[J].中华临床医师杂志（电子版）,2015,9(21):4-6.
